Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Public ClinicalTrials.gov record NCT02105012. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Chronic Dosing (4 Weeks), Four-Period, Five-Treatment, Incomplete Block, Cross-Over, Multi-Center Study to Assess the Efficacy and Safety of Four Doses of Budesonide Inhalation Aerosol (BD MDI, PT008) Relative to Placebo MDI in Adult Subjects With Mild to Moderate Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to assess the efficacy and safety of four doses of budesonide inhalation aerosol (BD MDI, PT008) relative to placebo MDI in adult subjects with mild to moderate persistent asthma.
Study identification
- NCT ID
- NCT02105012
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 147 participants
Conditions and interventions
Conditions
Interventions
- BD MDI 320 µg Drug
- BD MDI 160 µg Drug
- BD MDI 80 µg Drug
- BD MDI 40 µg Drug
- Placebo MDI Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2014 (Actual)
- Primary completion
- Sep 1, 2015 (Actual)
- Completion
- Sep 4, 2015 (Actual)
- Last update posted
- Jun 6, 2017
2014 – 2015
United States locations
- U.S. sites
- 41
- U.S. states
- 16
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pearl Therapeutics Study Site | Athens | Alabama | — | — |
| Pearl Therapeutics Study Site | Birmingham | Alabama | — | — |
| Pearl Therapeutics Study Site | Foley | Alabama | — | — |
| Pearl Therapeutics Study Site | Los Angeles | California | — | — |
| Pearl Therapeutics | Los Angeles | California | — | — |
| Pearl Therapeutics Study Site | Rolling Hills Estates | California | — | — |
| Pearl Therapeutics Study Site | San Diego | California | — | — |
| Pearl Therapeutics Study Site | Stockton | California | — | — |
| Pearl Therapeutics Study Site | Clearwater | Florida | — | — |
| Pearl Therapeutics Study Site | Clermont | Florida | — | — |
| Pearl Therapeutics Study Site | Miami | Florida | — | — |
| Pearl Therapeutics Study Site | Orlando | Florida | — | — |
| Pearl Therapeutics Study Site | Ormond Beach | Florida | — | — |
| Pearl Therapeutics Study Site | Saint Cloud | Florida | — | — |
| Pearl Therapeutics Study Site | Sebring | Florida | — | — |
| Pearl Therapeutics Study Site | Tampa | Florida | — | — |
| Pearl Therapeutics Study Site | Blue Island | Illinois | — | — |
| Pearl Therapeutics Study Site | North Dartmouth | Massachusetts | — | — |
| Pearl Therapeutics Study Site | Hazelwood | Missouri | — | — |
| Pearl Therapeutics Study Site | Skillman | New Jersey | — | — |
| Pearl Therapeutics Study Site | Charlotte | North Carolina | — | — |
| Pearl Therapeutics Study Site | Winston-Salem | North Carolina | — | — |
| Pearl Therapeutics Study Site | Cincinnati | Ohio | — | — |
| Pearl Therapeutics Study Site | Columbus | Ohio | — | — |
| Pearl Therapeutics Study Site | Dayton | Ohio | — | — |
| Pearl Therapeutics Study Site | Middleburg Heights | Ohio | — | — |
| Pearl Therapeutics Study Site | Oregon | Ohio | — | — |
| Pearl Therapeutics Study Site | Sylvania | Ohio | — | — |
| Pearl Therapeutics Study Site | Toledo | Ohio | — | — |
| Pearl Therapeutics Study Site | Oklahoma City | Oklahoma | — | — |
| Pearl Therapeutics Study Site | Lake Oswego | Oregon | — | — |
| Pearl Therapeutics Study Site | Medford | Oregon | — | — |
| Pearl Therapeutics Study Site | Greenville | South Carolina | — | — |
| Pearl Therapeutics Study Site | Spartanburg | South Carolina | — | — |
| Pearl Therapeutics Study Site | Rapid City | South Dakota | — | — |
| Pearl Therapeutics Study Site | Tullahoma | Tennessee | — | — |
| Pearl Therapeutics Study Site | El Paso | Texas | — | — |
| Pearl Therapeutics Study Site | Houston | Texas | — | — |
| Pearl Therapeutics Study Site | Plano | Texas | — | — |
| Pearl Therapeutics Study Site | San Antonio | Texas | — | — |
| Pearl Therapeutics Study Site | Everett | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02105012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 6, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02105012 live on ClinicalTrials.gov.